Frontlight ResearchEarly access
Taking peopleNo phase
MPS (RaDiCo Cohort) (RaDiCo-MPS)
Key facts
- Who runs it
- Institut National de la Santé Et de la Recherche Médicale, France
- Where
- France23 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 20 Dec 2017
- Expected to end
- Dec 2026
- Type of study
- Observational
- Record updated
- 11 February 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Confirmed diagnosis of MPS based on clinically relevant enzyme deficiency, with abnormally elevated GAG urinary excretion and/or identification of pathogenic mutations
- Signed informed consent or parents/guardian non-opposition for deceased patients (minor or protected major); There are no non-inclusion criteria
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Mucopolysaccharidosis Patients in France in the Era of Specific Therapeutics
- Record updated
- 11 February 2026